EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,874,659 | -10.5% | 1,736,503 | -2.6% | 0.03% | -8.8% |
| Q2 2023 | $15,505,592 | +170.5% | 1,782,252 | -8.6% | 0.03% | +161.5% |
| Q1 2023 | $5,733,000 | -16.0% | 1,950,000 | 0.0% | 0.01% | -18.8% |
| Q4 2022 | $6,825,000 | -55.8% | 1,950,000 | 0.0% | 0.02% | -57.9% |
| Q3 2022 | $15,425,000 | +0.5% | 1,950,000 | 0.0% | 0.04% | +8.6% |
| Q2 2022 | $15,347,000 | -35.2% | 1,950,000 | 0.0% | 0.04% | -22.2% |
| Q1 2022 | $23,693,000 | -0.7% | 1,950,000 | 0.0% | 0.04% | +4.7% |
| Q4 2021 | $23,868,000 | +29.9% | 1,950,000 | +10.6% | 0.04% | +19.4% |
| Q3 2021 | $18,371,000 | +27.7% | 1,763,031 | +10.2% | 0.04% | +28.6% |
| Q2 2021 | $14,384,000 | -6.7% | 1,600,000 | +5.4% | 0.03% | -9.7% |
| Q1 2021 | $15,425,000 | – | 1,518,211 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |